![Ursula Ney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ursula Ney
Direktor/Vorstandsmitglied bei
PROTEOME SCIENCES PLC
Profil
Dr. Ursula M.
Ney is an Independent Non-Executive Director at Scancell Holdings Plc and an Independent Non-Executive Director at Proteome Sciences Plc.
She is on the Board of Directors at Scancell Holdings Plc, Proteome Sciences Plc, University of Plymouth and University of Plymouth Enterprise Ltd. Dr. Ney was previously employed as a Non-Executive Director by Discuva Ltd., a Chief Operating Officer & Executive Director by Sarossa Capital Plc, a Chief Executive Officer by Charterhouse Therapeutics Ltd., a CEO, Director & Media Relations Contact by Calliditas Therapeutics Suisse SA, a Director & Development Director by Celltech Group Ltd., a Principal by Roche Diagnostics Ltd., and a Principal by Sandoz AG.
She also served on the board at Affibody AB and Celltech Americas, Inc. She received her MBA from Middlesex University Business School, a doctorate degree from UCL Medical School and a doctorate degree from Royal Free Hospital Medical School.
Aktive Positionen von Ursula Ney
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTEOME SCIENCES PLC | Direktor/Vorstandsmitglied | 01.08.2017 |
| SCANCELL HOLDINGS PLC | Direktor/Vorstandsmitglied | 23.10.2019 |
University of Plymouth
 University of Plymouth Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
University of Plymouth Enterprise Ltd.
 University of Plymouth Enterprise Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in exploitation of assets and intellectual property | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ursula Ney
| Unternehmen | Position | Ende |
|---|---|---|
Discuva Ltd.
 Discuva Ltd. Pharmaceuticals: MajorHealth Technology Develops antibiotics and drug-resistant pathogens | Direktor/Vorstandsmitglied | 01.12.2017 |
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Provides investment services | Geschäftsführer | 31.03.2010 |
Roche Diagnostics Ltd.
 Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops diagnostic tests and instruments | Corporate Officer/Principal | - |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Corporate Officer/Principal | - |
Celltech Group Ltd.
 Celltech Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | - |
Ausbildung von Ursula Ney
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
49
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Affibody AB
 Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Calliditas Therapeutics Suisse SA
 Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Proteome Sciences Plc
 Proteome Sciences Plc Medical SpecialtiesHealth Technology Develops medical diagnostics used to identify specific diseases | Health Technology |
Sarossa Capital Ltd.
Sarossa Capital Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars | Health Technology |
University of Plymouth
University of Plymouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celltech Americas, Inc. | |
Scancell Holdings Plc
 Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Charterhouse Therapeutics Ltd. | |
Celltech Group Ltd.
Celltech Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Roche Diagnostics Ltd.
Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops diagnostic tests and instruments | Health Technology |
Discuva Ltd.
Discuva Ltd. Pharmaceuticals: MajorHealth Technology Develops antibiotics and drug-resistant pathogens | Health Technology |
Middlesex University Business School
 Middlesex University Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCL Medical School
 UCL Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Free Hospital Medical School
 Royal Free Hospital Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Plymouth Enterprise Ltd.
University of Plymouth Enterprise Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in exploitation of assets and intellectual property | Commercial Services |
